Dendrobium officinale inhibits colorectal cancer progression by induction of glutathione peroxidase 4-mediated ferroptosis

Abstract

Colorectal cancer (CRC), one of the leading causes of cancer-related mortality globally, urgently requires complementary and alternative therapies. Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, has emerged as a promising anti-cancer strategy. Dendrobium officinale (D. officinale), a renowned traditional Chinese medicinal herb, is widely used in several Asian countries for its nutritional and therapeutic benefits. Although D. officinale has demonstrated anti-tumor effects, the molecular mechanisms underlying its action against CRC remain incompletely characterized. This study aimed to elucidate the role of D. officinale in suppressing CRC through the induction of ferroptosis and its regulatory effects on glutathione peroxidase 4 (GPX4), a key suppressor of ferroptosis. In vitro assays were conducted using HCT116 and SW480 CRC cell lines, and in vivo efficacy was evaluated in BALB/c nude mice bearing CRC xenografts. D. officinale significantly reduced CRC cell viability and proliferation in vitro and suppressed tumor growth in vivo. Induction of ferroptosis was evidenced by elevated levels of Fe²⁺, malondialdehyde (MDA), and lipid peroxidation, along with a depleted glutathione/oxidized glutathione disulfide (GSH/GSSG) ratio. Notably, these effects were reversed by ferroptosis inhibitors, including ferrostatin-1 (Fer-1) and deferoxamine. Consistently, D. officinale markedly downregulated GPX4 expression. Overexpression of GPX4 rescued D. officinale-induced ferroptosis, whereas GPX4 silencing exacerbated this effect. D. officinale suppresses CRC by triggering GPX4-dependent ferroptosis, providing a novel, naturally derived therapeutic approach. These findings bridge traditional medicine and modern oncology, establishing a foundation for developing targeted CRC treatments.

Keywords

Colorectal cancer / Dendrobium officinale / Ferroptosis / Glutathione peroxidase 4 / Lipid peroxidation

Funding

This work was supported by the Department of Education of Guangdong Province (No. 2023KTSCX024), the Project of Traditional Chinese Medicine Bureau of Guangdong Province (No.20251091), the Joint Funds of the National Natural Science Foundation of China (No. U22A20368), the Key-Area Research and Development Program of Guangdong Province (No. R. Jiang et al. Chinese Journal of Natural Medicines 24 (2026) 338-348 2020B1111100004), Guangdong Basic and Applied Basic Research Foundation (No. 2020B1515130005), and Shenzhen Baoan District Science and Technology Innovation Bureau Project (Nos. 2022JD226 and 2023JD252).

Supporting information

Supplementary data associated with this article can bere-quested by sending E-mail to the corresponding authors.

Declaration of competing interest

These authors have no conflict of interest to declare.

References

[1] Akiyama H, Zhao R, Ostermann LB, et al. Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia. Leukemia. 2024; 38(4):729-740. https://doi.org/10.1038/s41375-023-02117-2.

[2] Cao W, Zhang X, Feng Y, et al. Lipid nanoparticular codelivery system for enhanced antitumor effects by ferroptosis-apoptosis synergistic with programmed cell death-ligand 1 downregulation. ACS Nano. 2024; 18(26):17267-17281. https://doi.org/10.1021/acsnano.4c04901.

[3] Cheff DM, Huang C, Scholzen KC, et al. The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1. Redox Biol. 2025; 62:102703. https://doi.org/10.1016/j.redox.2023.102703.

[4] Chen WH, Wu JJ, Li XF, et al. Isolation, structural properties, bioactivities of polysaccharides from Dendrobium officinale Kimura et. Migo: a review. Int J Biol Macromol. 2021; 184:1000-1013. https://doi.org/10.1016/j.ijbiomac.2021.06.156.

[5] Chu W, Wang P, Ma Z, et al. Ultrasonic treatment of Dendrobium officinale polysaccharide enhances antioxidant and anti-inflammatory activity in a mouse D-galactose-induced aging model. Food Sci Nutr. 2022; 10(8):2620-2630. https://doi.org/10.1002/fsn3.2867.

[6] Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019; 394(10207):1467-1480. https://doi.org/10.1016/s0140-6736(19)32319-0.

[7] Hu JL, Wang W, Lan XL, et al. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Mol Cancer. 2019; 18(1):91. https://doi.org/10.1186/s12943-019-1019-x.

[8] Jiang W, Tan J, Zhang J, et al. Polysaccharides from Dendrobium officinale improve obesity-induced insulin resistance through the gut microbiota and the SOCS3-mediated insulin receptor substrate-1 signaling pathway. J Sci Food Agric. 2024; 104(6):3437-3447. https://doi.org/10.1002/jsfa.13229.

[9] Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021; 22(4):266-282. https://doi.org/10.1038/s41580-020-00324-8.

[10] Li M, Yue H, Wang Y, et al. Intestinal microbes derived butyrate is related to the immunomodulatory activities of Dendrobium officinale polysaccharide. Int J Biol Macromol. 2020; 149:717-723. https://doi.org/10.1016/j.ijbiomac.2020.01.305.

[11] Liang J, Wu Y, Yuan H, et al. Dendrobium officinale polysaccharides attenuate learning and memory disabilities via anti-oxidant and anti-inflammatory actions. Int J Biol Macromol. 2019; 126:414-426. https://doi.org/10.1016/j.ijbiomac.2018.12.230.

[12] Lin A, Giuliano CJ, Palladino A, et al. Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials. Sci Transl Med. 2019; 11(509):aaw8412. https://doi.org/10.1126/scitranslmed.aaw8412.

[13] Lin Y, Zhang Y, Wang D, et al. Computer especially AI-assisted drug virtual screening and design in traditional Chinese medicine. Phytomedicine. 2022; 107:154481. https://doi.org/10.1016/j.phymed.2022.154481.

[14] Liu Y, Wan Y, Jiang Y, et al. GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment. Biochim Biophys Acta Rev Cancer. 2023; 1878(3): 188890. https://doi.org/10.1016/j.bbcan.2023.188890.

[15] Niu B, Liao K, Zhou Y, et al. Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials. 2021; 277:121110. https://doi.org/10.1016/j.biomaterials.2021.121110.

[16] Pan H, Gray R, Braybrooke J, et al. 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med. 2017; 377(19):1836-1846. https://doi.org/10.1056/NEJMoa1701830.

[17] Prutki M, Poljak-Blazi M, Jakopovic et al. Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer. Cancer Lett. 2006; 238(2):188-196. https://doi.org/10.1016/j.canlet.2005.07.001.

[18] Ruan J, Zhang P, Zhang Q, et al. Colorectal cancer inhibitory properties of polysaccharides and their molecular mechanisms: a review. Int J Biol Macromol. 2023; 238:124165. https://doi.org/10.1016/j.ijbiomac.2023.124165.

[19] Yang J, Chen H, Nie Q, et al. Dendrobium officinale polysaccharide ameliorates the liver metabolism disorders of type II diabetic rats. Int J Biol Macromol. 2020; 164:1939-1948. https://doi.org/10.1016/j.ijbiomac.2020.08.007.

[20] Song X, Liu C, Zhang Y, et al. Sustainable extraction of ligustilide and ferulic acid from Angelicae Sinensis Radix, for antioxidant and anti-inflammatory activities. Ultrason Sonochem. 2023; 94:106344. https://doi.org/10.1016/j.ultsonch.2023.106344.

[21] Tang R, Xu J, Zhang B. et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020; 13(1):110. https://doi.org/10.1186/s13045-020-00946-7.

[22] Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med. 2020; 152:175-185. https://doi.org/10.1016/j.freeradbiomed.2020.02.027.

[23] Vasan N, Baselga J, Hyman D. A view on drug resistance in cancer. Nature. 2019; 575(7782):299-309. https://doi.org/10.1038/s41586-019-1730-1.

[24] Wang D, Liang W, Huo D, et al. SPY1 inhibits neuronal ferroptosis in amyotrophic lateral sclerosis by reducing lipid peroxidation through regulation of GCH1 and TFR1. Cell Death Differ. 2023; 30(2):369-382. https://doi.org/10.1038/s41418-022-01089-7.

[25] Wang K, Song M, Mu X, et al. Comparison and the lipid-lowering ability evaluation method discussion of Dendrobium officinale polysaccharides from different origins based on principal component analysis. Int J Biol Macromol. 2023; 242(Pt 1):124707. https://doi.org/10.1016/j.ijbiomac.2023.124707.

[26] Willems PH, Rossignol R, Dieteren CE, et al. Redox homeostasis and mitochondrial dynamics. Cell Metab. 2015; 22(2):207-218. https://doi.org/10.1016/j.cmet.2015.06.006.

[27] Xu X, Zhang C, Wang N, et al. Bioactivities and mechanism of actions of Dendrobium officinale: a comprehensive review. Oxid Med Cell Longev. 2022:6293355. https://doi.org/10.1155/2022/6293355.

[28] Xue D, Feng S, Zhao H, et al. The linkage maps of Dendrobium species based on RAPD and SRAP markers. J Genet Genomics. 2010; 37(3):197-204. https://doi.org/10.1016/s1673-8527(09)60038-2.

[29] Zhang K, Zhou X, Wang J, et al. Dendrobium officinale polysaccharide triggers mitochondrial disorder to induce colon cancer cell death via ROS-AMPK-autophagy pathway. Carbohydr Polym. 2021; 264:118018. https://doi.org/10.1016/j.carbpol.2021.118018.

[30] Zhang P, Zhang X, Zhu X, et al. Chemical constituents, bioactivities, and pharmacological mechanisms of Dendrobium officinale: a review of the past decade. J Agric Food Chem. 2023; 71(41):14870-14889. https://doi.org/10.1021/acs.jafc.3c04154.